Markel Non Current Liabilities Total vs Other Stockholder Equity Analysis
MKL Stock | USD 1,642 20.76 1.28% |
Markel financial indicator trend analysis is infinitely more than just investigating Markel recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Markel is a good investment. Please check the relationship between Markel Non Current Liabilities Total and its Other Stockholder Equity accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Markel. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in industry. For more information on how to buy Markel Stock please use our How to buy in Markel Stock guide.
Non Current Liabilities Total vs Other Stockholder Equity
Non Current Liabilities Total vs Other Stockholder Equity Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Markel Non Current Liabilities Total account and Other Stockholder Equity. At this time, the significance of the direction appears to have pay attention.
The correlation between Markel's Non Current Liabilities Total and Other Stockholder Equity is -0.77. Overlapping area represents the amount of variation of Non Current Liabilities Total that can explain the historical movement of Other Stockholder Equity in the same time period over historical financial statements of Markel, assuming nothing else is changed. The correlation between historical values of Markel's Non Current Liabilities Total and Other Stockholder Equity is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Current Liabilities Total of Markel are associated (or correlated) with its Other Stockholder Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Stockholder Equity has no effect on the direction of Non Current Liabilities Total i.e., Markel's Non Current Liabilities Total and Other Stockholder Equity go up and down completely randomly.
Correlation Coefficient | -0.77 |
Relationship Direction | Negative |
Relationship Strength | Weak |
Non Current Liabilities Total
Other Stockholder Equity
Most indicators from Markel's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Markel current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Markel. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in industry. For more information on how to buy Markel Stock please use our How to buy in Markel Stock guide.At this time, Markel's Tax Provision is quite stable compared to the past year. Enterprise Value is expected to rise to about 15.4 B this year, although the value of Selling General Administrative will most likely fall to about 613.3 M.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 12.8B | 11.6B | 15.6B | 16.4B | Total Revenue | 12.9B | 11.8B | 15.8B | 16.6B |
Markel fundamental ratios Correlations
Click cells to compare fundamentals
Markel Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Markel fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 37.5B | 41.7B | 48.5B | 63.4B | 43.4B | 45.6B | |
Short Long Term Debt Total | 3.5B | 3.5B | 4.4B | 4.1B | 4.4B | 4.7B | |
Total Stockholder Equity | 11.1B | 12.8B | 14.7B | 13.1B | 15.0B | 15.7B | |
Net Debt | 461.4M | (857.7M) | 382.8M | (33.8M) | 105.0M | 99.7M | |
Retained Earnings | 7.5B | 8.2B | 10.4B | 9.8B | 11.4B | 11.9B | |
Common Stock Shares Outstanding | 13.9M | 13.8M | 13.8M | 13.6M | 13.4M | 9.9M | |
Liabilities And Stockholders Equity | 48.7B | 41.7B | 63.6B | 63.4B | 43.4B | 45.6B | |
Non Current Liabilities Total | 3.5B | 3.5B | 4.4B | 4.1B | 12.4B | 13.0B | |
Other Stockholder Equity | 937.6M | 592.3M | 614.75 | (13.1B) | (11.8B) | (11.2B) | |
Total Liab | 19.4B | 21.2B | 24.2B | 25.5B | 27.9B | 29.3B | |
Property Plant And Equipment Net | 441.9M | 1.2B | 1.6B | 1.7B | 1.9B | 2.0B | |
Non Current Assets Total | 22.8B | 24.1B | 27.7B | 4.4B | 31.9B | 33.5B | |
Non Currrent Assets Other | (22.8B) | (1.2B) | (1.7B) | (24.0B) | 25.1B | 26.4B | |
Intangible Assets | 1.7B | 1.8B | 1.8B | 1.7B | 1.6B | 1.7B | |
Other Assets | (6.9B) | (7.4B) | (7.3B) | 56.1B | 19.4B | 10.8B | |
Net Receivables | 7.3B | 7.9B | 9.7B | 11.4B | 12.7B | 13.3B | |
Total Current Assets | 21.5B | 25.0B | 28.1B | 3.0B | 11.5B | 6.5B | |
Cash | 3.1B | 4.3B | 4.0B | 4.1B | 4.3B | 4.5B | |
Cash And Short Term Investments | 14.2B | 17.1B | 18.4B | 18.7B | 10.2B | 7.8B | |
Short Term Investments | 11.2B | 12.7B | 14.4B | 14.5B | 3.8B | 6.0B | |
Accumulated Other Comprehensive Income | 208.8M | 584.4M | 237.6M | (857.1M) | (478.2M) | (454.3M) | |
Other Current Liab | (5.7B) | (6.2B) | (7.5B) | (8.7B) | 14.2B | 15.0B | |
Total Current Liabilities | 5.7B | 6.2B | 7.5B | 8.7B | 15.5B | 16.3B | |
Other Liab | 17.9B | 19.7B | 22.3B | 24.6B | 28.3B | 29.7B | |
Accounts Payable | 5.7B | 6.2B | 7.5B | 8.7B | 1.0B | 985.8M | |
Long Term Debt | 3.5B | 3.5B | 4.4B | 4.1B | 3.8B | 2.1B | |
Good Will | 2.3B | 2.6B | 2.9B | 2.6B | 2.6B | 2.8B | |
Common Stock | 3.4B | 3.4B | 3.4B | 3.5B | 3.5B | 2.2B | |
Property Plant Equipment | 588.6M | 632M | 1.6B | 1.7B | 2.0B | 2.1B | |
Other Current Assets | (303.1M) | 9.6B | 9.1B | (447K) | 11.5B | 12.1B | |
Short Term Debt | 113.0M | 126.8M | 0.0 | 500.5M | 202.0M | 191.9M | |
Net Tangible Assets | 7.2B | 8.1B | 9.0B | 8.6B | 9.9B | 6.4B | |
Noncontrolling Interest In Consolidated Entity | 7.5M | 14.9M | 22.9M | 62.8M | 72.2M | 75.8M | |
Common Stock Total Equity | 3.4B | 3.4B | 3.4B | 3.5B | 4.0B | 3.1B | |
Retained Earnings Total Equity | 7.5B | 8.2B | 10.4B | 9.8B | 11.3B | 11.9B | |
Inventory | 303.1M | (9.6B) | (9.1B) | (27.1B) | (22.9B) | (21.8B) | |
Long Term Investments | 18.8B | 19.7B | 23.4B | 22.2B | 26.5B | 18.1B | |
Non Current Liabilities Other | 22.7B | 25.2B | 28.9B | 32.0B | 36.8B | 19.4B | |
Warrants | 177.6M | 245.6M | 461.4M | 523.2M | 601.6M | 631.7M |
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Markel using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Markel. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in industry. For more information on how to buy Markel Stock please use our How to buy in Markel Stock guide.You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Complementary Tools for Markel Stock analysis
When running Markel's price analysis, check to measure Markel's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Markel is operating at the current time. Most of Markel's value examination focuses on studying past and present price action to predict the probability of Markel's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Markel's price. Additionally, you may evaluate how the addition of Markel to your portfolios can decrease your overall portfolio volatility.
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |
Is Markel's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Markel. If investors know Markel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Markel listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.024 | Earnings Share 185.1 | Revenue Per Share 1.3 K | Quarterly Revenue Growth 0.226 | Return On Assets 0.0405 |
The market value of Markel is measured differently than its book value, which is the value of Markel that is recorded on the company's balance sheet. Investors also form their own opinion of Markel's value that differs from its market value or its book value, called intrinsic value, which is Markel's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Markel's market value can be influenced by many factors that don't directly affect Markel's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Markel's value and its price as these two are different measures arrived at by different means. Investors typically determine if Markel is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Markel's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.